Abstract
In order to determine the changes in the pattern of techniques applied during elective coronary intervention, data from 688 patients prior to Sirolimus. Drug-Eluting Stents (DES) approval was compared to 438 patients who underwent coronary intervention after DES approval. There was increased intervention to higher risk lesions, including smaller vessels and re-stenotic lesions after DES approval. Total number of stents per patient significantly decreased, despite longer stent length per patient or per lesion after DES approval. No significant difference was found in multivessel interventions.
Original language | English (US) |
---|---|
Pages (from-to) | 279-280 |
Number of pages | 2 |
Journal | International Journal of Cardiology |
Volume | 113 |
Issue number | 2 |
DOIs | |
State | Published - Nov 10 2006 |
Externally published | Yes |
Keywords
- Drug Eluting Stent
- Percutaneous coronary intervention
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine